KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Invested Capital (2018 - 2024)

Historic Return on Invested Capital for Sarepta Therapeutics (SRPT) over the last 9 years, with Q2 2025 value amounting to 0.25%.

  • Sarepta Therapeutics' Return on Invested Capital rose 2400.0% to 0.25% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.25%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 0.08% for FY2024, which is 2200.0% up from last year.
  • According to the latest figures from Q2 2025, Sarepta Therapeutics' Return on Invested Capital is 0.25%, which was up 2400.0% from 0.08% recorded in Q4 2024.
  • Sarepta Therapeutics' Return on Invested Capital's 5-year high stood at 0.25% during Q2 2025, with a 5-year trough of 0.59% in Q2 2021.
  • Over the past 5 years, Sarepta Therapeutics' median Return on Invested Capital value was 0.27% (recorded in 2022), while the average stood at 0.22%.
  • In the last 5 years, Sarepta Therapeutics' Return on Invested Capital tumbled by -400bps in 2023 and then skyrocketed by 2900bps in 2024.
  • Sarepta Therapeutics' Return on Invested Capital (Quarter) stood at 0.36% in 2021, then grew by 23bps to 0.28% in 2022, then skyrocketed by 52bps to 0.13% in 2023, then skyrocketed by 157bps to 0.08% in 2024, then skyrocketed by 230bps to 0.25% in 2025.
  • Its Return on Invested Capital was 0.25% in Q2 2025, compared to 0.08% in Q4 2024 and 0.03% in Q3 2024.